CellCept®for Living

CellCept Coupon Card >Start saving on your prescriptions today!

It's easy! Just call 1-877-509-CCFL (2235) to receive your ready-to-use CellCept Coupon Card for up to $100 toward every CellCept prescription and refill. Click here for details
or sign up for a downloadable
coupon card.

CellCept for Living is a free program, paid for by Roche, that provides you with the information you need for a stronger, more rewarding life now and in the days and years ahead. While the Coupon Card is available to you whether or not you are enrolled in CellCept for Living, we hope that you will take advantage of all the benefits this program can offer you

Enroll Now!

E-mail Address

Password

Forgot your password?
Click Here.

Indications:

CellCept^® (mycophenolate mofetil) is given to people who have received kidney, heart or liver transplants in order to prevent rejection, a process where the immune system perceives the new organ as a "foreign" threat and attacks it.

CellCept, an immunosuppressant medication, is taken along with other antirejection drugs. Please follow your doctor's exact instructions for taking CellCept and all other medications.

Important Safety Information:

WARNING:

The use of CellCept in combination with other antirejection medications may result in an increased susceptibility to infection and the possible development of lymphomas. Contact your doctor right away if you notice any signs of infection (such as fever, tiredness, headache, redness of skin/wound or enlarged glands).

Women of childbearing potential must use contraception. Use of CellCept during pregnancy is associated with increased risk of miscarriage and congenital malformations (birth defects).

The most common side effects of CellCept include: diarrhea, leukopenia (a decrease in white blood cells), sepsis (an infection in the blood), vomiting and a higher incidence of certain infections. People taking CellCept in combination with other antirejection medications have a greater chance of developing lymphomas and other cancers, especially skin cancer.
If you are a woman of childbearing age, you must use 2 highly effective methods of contraception 4 weeks prior to starting CellCept therapy and continue contraception until 6 weeks after stopping CellCept treatment, unless abstinence is the chosen method. If you are considering pregnancy, be sure to talk to your doctor, as CellCept should not be used unless you cannot be successfully treated with other immunosuppressant drugs.
Cases of progressive multifocal leukoencephalopathy (PML), an infection of the brain that is sometimes fatal, have been reported in patients treated with CellCept. In reported cases, patients generally had risk factors for PML, including treatment with immunosuppressant therapies. The most common symptoms may include: clumsiness, progressive weakness, loss of movement or function in one side of the body, and changes in vision, speech or personality.
Severe neutropenia (a decrease in neutrophils, a type of white blood cell) has been reported in up to 2% of kidney, 2.8% of heart and 3.6% of liver transplant patients receiving CellCept at a dose of 3 grams daily.
Gastrointestinal bleeding (requiring hospitalization) has been reported in approximately 3% of kidney, 1.7% of heart and 5.4% of liver transplant patients treated with CellCept at a dose of 3 grams daily.

Please be sure to talk to your doctor if you have any questions about your condition or treatment.

please see Complete Prescribing Information with Medication Guide.